Letters & Comments

NHC Comments on ICER Solicitation for Feedback on the 2020 Value Assessment Framework
(Monday, June 10, 2019 04:15 PM)
NHC Comments on House Medicare Part D Reform Legislation
(Thursday, June 6, 2019 05:00 PM)
NHC Comments on Senate Committee on Health, Education, Labor, and Pensions Draft Legislation to Reduce Health Care Costs
(Wednesday, June 5, 2019 03:45 PM)
NHC Comments on HHS Proposal to Amend Safe Harbor Regulation
(Monday, April 8, 2019 03:15 PM)
NHC Comments on HELP Committee Request for Information on Lowering Health Care Costs
(Wednesday, March 20, 2019 05:15 PM)
NHC Comments on Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2020
(Tuesday, February 19, 2019 04:00 PM)
NHC Comments on ICER Unsupported Price Increase Assessment
(Wednesday, February 13, 2019 04:30 PM)
NHC Comments on Framework for a Real-World Evidence Program; Availability
(Thursday, February 7, 2019 11:00 AM)
NHC Comments on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses
(Friday, January 25, 2019 06:30 PM)
NHC Comments on Patient Engagement in Medical Device Clinical Trials Discussion Document
(Tuesday, January 8, 2019 04:30 PM)
NHC Comments on Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs
(Monday, December 31, 2018 01:30 PM)
NHC Letter on State Relief and Empowerment Waivers
(Monday, December 24, 2018 01:30 PM)
NHC Comments on Patient-Focused Drug Development Guidance: Methods To Identify What Is Important to Patients and Select, Develop, or Modify Fit-for-Purpose Clinical Outcome Assessments
(Friday, December 14, 2018 02:30 PM)
NHC Comments on Accountable Care Organizations Pathways to Success
(Tuesday, October 16, 2018 02:15 PM)
NHC Comments on FDA Standard Core Clinical Outcome Assessments and Endpoints
(Monday, October 15, 2018 12:00 PM)
Letter to Secretary Azar on the Administration's Step Therapy Policy
(Wednesday, September 26, 2018 05:00 PM)
NHC Comments on Medicare Program: Proposed Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs
(Wednesday, September 26, 2018 12:00 PM)
NHC Comments on the FDA’s Draft Guidance on Patient-Focused Drug Development: Collecting Comprehensive and Representative Input
(Tuesday, September 11, 2018 04:30 PM)
NHC Comments on the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs
(Monday, July 16, 2018 05:00 PM)
NHC Comments on Proposed Rule, Short-Term, Limited-Duration Insurance
(Monday, April 23, 2018 (All day))

Pages